JOHN MARTIN DOCHERTY - 29 Jul 2025 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
President & CSO, Director
Signature
/John Docherty/
Issuer symbol
LEXX
Transactions as of
29 Jul 2025
Net transactions value
+$4,989
Form type
4
Filing time
30 Jul 2025, 11:34:10 UTC
Previous filing
16 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DOCHERTY JOHN MARTIN President & CSO, Director 23 MIKELEN DRIVE, PORT PERRY, ONTARIO, CANADA /John Docherty/ 30 Jul 2025 0001638727

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LEXX common shares Purchase $4,989 +5,376 $0.9280 5,376 29 Jul 2025 Direct
holding LEXX common shares 54,075 29 Jul 2025 Private Holding Company

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LEXX Stock Options 18,000 29 Jul 2025 Common Shares 18,000 $3.00 Direct
holding LEXX Stock Options 36,334 29 Jul 2025 Common Shares 18,334 $3.00 Direct
holding LEXX Stock Options 51,334 29 Jul 2025 Common Shares 15,000 $3.00 Direct
holding LEXX Stock Options 81,334 29 Jul 2025 Common Shares 30,000 $2.91 Direct
holding LEXX Stock Options 111,334 29 Jul 2025 Common Shares 30,000 $1.15 Direct
holding LEXX Stock Options 160,834 29 Jul 2025 Common Shares 49,500 $2.36 Direct
holding LEXX Stock Options 310,834 29 Jul 2025 Common Shares 150,000 $1.04 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.